ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Kintor Pharmaceutical Announced FDA Has Greenlighted Pyrilutamide's Phase II Clinical Trial for Androgenetic Alopecia in the US
July 13, 2021Kintor Pharmaceutical Limited announced that the U.S. Food and Drug Administration (FDA) has greenlighted pyrilutamide's phase II clinical trial for androgenetic alopecia(AGA) to be conducted in the US. -
Kintor Pharmaceuticals Announced Successful Dosing of the First Batch of Patients for Acne Vulgaris Phase I/II Clinical Trial of Pyrilutamide
April 19, 2021Kintor Pharmaceutical Limited, a clinical-stage biotechnology company developing small molecule and biological therapeutics, announced the clinical trial of Pyrilutamide as a treatment for the acne vulgaris has completed the first batch of patients ...
Pharma Sources Insight January 2025
